The dropless future: SLT as a first-line treatment for glaucoma Dr. Kristin O. Chapman explains how SLT’s promotion to first-line therapy is changing the age-old battle for glaucoma drop tolerance and adherence. Read Full ArticleKristin O. Chapman, MD Explore Other Resources Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubOD Brings In Technology To Help Patients Get Off The Hamster Wheel Of Dry Eye TreatmentsDry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubTeaching Peers About Dry Eye Disease Boosts Patients’ Access to CareDry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubHow a Boutique Dry Eye Clinic in an Unexpected Spot Drew $45,000 in the First 9 Months. PB-00038930 Rev A
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubOD Brings In Technology To Help Patients Get Off The Hamster Wheel Of Dry Eye Treatments
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubTeaching Peers About Dry Eye Disease Boosts Patients’ Access to Care
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubHow a Boutique Dry Eye Clinic in an Unexpected Spot Drew $45,000 in the First 9 Months.